1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Original Brand Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Prescription Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Online
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Prescription Medicine Market Perspective (2017-2028)
2.2 Prescription Medicine Growth Trends by Region
2.2.1 Prescription Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prescription Medicine Historic Market Size by Region (2017-2022)
2.2.3 Prescription Medicine Forecasted Market Size by Region (2023-2028)
2.3 Prescription Medicine Market Dynamics
2.3.1 Prescription Medicine Industry Trends
2.3.2 Prescription Medicine Market Drivers
2.3.3 Prescription Medicine Market Challenges
2.3.4 Prescription Medicine Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Prescription Medicine Players by Revenue
3.1.1 Global Top Prescription Medicine Players by Revenue (2017-2022)
3.1.2 Global Prescription Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Prescription Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prescription Medicine Revenue
3.4 Global Prescription Medicine Market Concentration Ratio
3.4.1 Global Prescription Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Medicine Revenue in 2021
3.5 Prescription Medicine Key Players Head office and Area Served
3.6 Key Players Prescription Medicine Product Solution and Service
3.7 Date of Enter into Prescription Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Prescription Medicine Breakdown Data by Type
4.1 Global Prescription Medicine Historic Market Size by Type (2017-2022)
4.2 Global Prescription Medicine Forecasted Market Size by Type (2023-2028) 5 Prescription Medicine Breakdown Data by Application
5.1 Global Prescription Medicine Historic Market Size by Application (2017-2022)
5.2 Global Prescription Medicine Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Prescription Medicine Market Size (2017-2028)
6.2 North America Prescription Medicine Market Size by Type
6.2.1 North America Prescription Medicine Market Size by Type (2017-2022)
6.2.2 North America Prescription Medicine Market Size by Type (2023-2028)
6.2.3 North America Prescription Medicine Market Share by Type (2017-2028)
6.3 North America Prescription Medicine Market Size by Application
6.3.1 North America Prescription Medicine Market Size by Application (2017-2022)
6.3.2 North America Prescription Medicine Market Size by Application (2023-2028)
6.3.3 North America Prescription Medicine Market Share by Application (2017-2028)
6.4 North America Prescription Medicine Market Size by Country
6.4.1 North America Prescription Medicine Market Size by Country (2017-2022)
6.4.2 North America Prescription Medicine Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Prescription Medicine Market Size (2017-2028)
7.2 Europe Prescription Medicine Market Size by Type
7.2.1 Europe Prescription Medicine Market Size by Type (2017-2022)
7.2.2 Europe Prescription Medicine Market Size by Type (2023-2028)
7.2.3 Europe Prescription Medicine Market Share by Type (2017-2028)
7.3 Europe Prescription Medicine Market Size by Application
7.3.1 Europe Prescription Medicine Market Size by Application (2017-2022)
7.3.2 Europe Prescription Medicine Market Size by Application (2023-2028)
7.3.3 Europe Prescription Medicine Market Share by Application (2017-2028)
7.4 Europe Prescription Medicine Market Size by Country
7.4.1 Europe Prescription Medicine Market Size by Country (2017-2022)
7.4.2 Europe Prescription Medicine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Prescription Medicine Market Size (2017-2028)
8.2 Asia-Pacific Prescription Medicine Market Size by Type
8.2.1 Asia-Pacific Prescription Medicine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prescription Medicine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prescription Medicine Market Share by Type (2017-2028)
8.3 Asia-Pacific Prescription Medicine Market Size by Application
8.3.1 Asia-Pacific Prescription Medicine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Prescription Medicine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Prescription Medicine Market Share by Application (2017-2028)
8.4 Asia-Pacific Prescription Medicine Market Size by Region
8.4.1 Asia-Pacific Prescription Medicine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prescription Medicine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Prescription Medicine Market Size (2017-2028)
9.2 Latin America Prescription Medicine Market Size by Type
9.2.1 Latin America Prescription Medicine Market Size by Type (2017-2022)
9.2.2 Latin America Prescription Medicine Market Size by Type (2023-2028)
9.2.3 Latin America Prescription Medicine Market Share by Type (2017-2028)
9.3 Latin America Prescription Medicine Market Size by Application
9.3.1 Latin America Prescription Medicine Market Size by Application (2017-2022)
9.3.2 Latin America Prescription Medicine Market Size by Application (2023-2028)
9.3.3 Latin America Prescription Medicine Market Share by Application (2017-2028)
9.4 Latin America Prescription Medicine Market Size by Country
9.4.1 Latin America Prescription Medicine Market Size by Country (2017-2022)
9.4.2 Latin America Prescription Medicine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Prescription Medicine Market Size (2017-2028)
10.2 Middle East & Africa Prescription Medicine Market Size by Type
10.2.1 Middle East & Africa Prescription Medicine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prescription Medicine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prescription Medicine Market Share by Type (2017-2028)
10.3 Middle East & Africa Prescription Medicine Market Size by Application
10.3.1 Middle East & Africa Prescription Medicine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Prescription Medicine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Prescription Medicine Market Share by Application (2017-2028)
10.4 Middle East & Africa Prescription Medicine Market Size by Country
10.4.1 Middle East & Africa Prescription Medicine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prescription Medicine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prescription Medicine Introduction
11.1.4 Pfizer Revenue in Prescription Medicine Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Prescription Medicine Introduction
11.2.4 Roche Revenue in Prescription Medicine Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Prescription Medicine Introduction
11.3.4 Novartis Revenue in Prescription Medicine Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Prescription Medicine Introduction
11.4.4 Johnson & Johnson Revenue in Prescription Medicine Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Prescription Medicine Introduction
11.5.4 Merck & Co. Revenue in Prescription Medicine Business (2017-2022)
11.5.5 Merck & Co. Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Prescription Medicine Introduction
11.6.4 Sanofi Revenue in Prescription Medicine Business (2017-2022)
11.6.5 Sanofi Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Prescription Medicine Introduction
11.7.4 AbbVie Revenue in Prescription Medicine Business (2017-2022)
11.7.5 AbbVie Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Prescription Medicine Introduction
11.8.4 GlaxoSmithKline Revenue in Prescription Medicine Business (2017-2022)
11.8.5 GlaxoSmithKline Recent Developments
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Prescription Medicine Introduction
11.9.4 Amgen Revenue in Prescription Medicine Business (2017-2022)
11.9.5 Amgen Recent Developments
11.10 Gilead Science
11.10.1 Gilead Science Company Details
11.10.2 Gilead Science Business Overview
11.10.3 Gilead Science Prescription Medicine Introduction
11.10.4 Gilead Science Revenue in Prescription Medicine Business (2017-2022)
11.10.5 Gilead Science Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Prescription Medicine Introduction
11.11.4 Bristol-Myers Squibb Revenue in Prescription Medicine Business (2017-2022)
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Prescription Medicine Introduction
11.12.4 AstraZeneca Revenue in Prescription Medicine Business (2017-2022)
11.12.5 AstraZeneca Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Prescription Medicine Introduction
11.13.4 Eli Lilly Revenue in Prescription Medicine Business (2017-2022)
11.13.5 Eli Lilly Recent Developments
11.14 Bayer
11.14.1 Bayer Company Details
11.14.2 Bayer Business Overview
11.14.3 Bayer Prescription Medicine Introduction
11.14.4 Bayer Revenue in Prescription Medicine Business (2017-2022)
11.14.5 Bayer Recent Developments
11.15 Novo Nordisk
11.15.1 Novo Nordisk Company Details
11.15.2 Novo Nordisk Business Overview
11.15.3 Novo Nordisk Prescription Medicine Introduction
11.15.4 Novo Nordisk Revenue in Prescription Medicine Business (2017-2022)
11.15.5 Novo Nordisk Recent Developments
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Prescription Medicine Introduction
11.16.4 Takeda Revenue in Prescription Medicine Business (2017-2022)
11.16.5 Takeda Recent Developments
11.17 Boehringer-Ingelheim
11.17.1 Boehringer-Ingelheim Company Details
11.17.2 Boehringer-Ingelheim Business Overview
11.17.3 Boehringer-Ingelheim Prescription Medicine Introduction
11.17.4 Boehringer-Ingelheim Revenue in Prescription Medicine Business (2017-2022)
11.17.5 Boehringer-Ingelheim Recent Developments
11.18 Allergan
11.18.1 Allergan Company Details
11.18.2 Allergan Business Overview
11.18.3 Allergan Prescription Medicine Introduction
11.18.4 Allergan Revenue in Prescription Medicine Business (2017-2022)
11.18.5 Allergan Recent Developments
11.19 Teva Pharmaceutical Industries
11.19.1 Teva Pharmaceutical Industries Company Details
11.19.2 Teva Pharmaceutical Industries Business Overview
11.19.3 Teva Pharmaceutical Industries Prescription Medicine Introduction
11.19.4 Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2017-2022)
11.19.5 Teva Pharmaceutical Industries Recent Developments
11.20 Mylan
11.20.1 Mylan Company Details
11.20.2 Mylan Business Overview
11.20.3 Mylan Prescription Medicine Introduction
11.20.4 Mylan Revenue in Prescription Medicine Business (2017-2022)
11.20.5 Mylan Recent Developments
11.21 Astellas Pharma
11.21.1 Astellas Pharma Company Details
11.21.2 Astellas Pharma Business Overview
11.21.3 Astellas Pharma Prescription Medicine Introduction
11.21.4 Astellas Pharma Revenue in Prescription Medicine Business (2017-2022)
11.21.5 Astellas Pharma Recent Developments
11.22 Biogen
11.22.1 Biogen Company Details
11.22.2 Biogen Business Overview
11.22.3 Biogen Prescription Medicine Introduction
11.22.4 Biogen Revenue in Prescription Medicine Business (2017-2022)
11.22.5 Biogen Recent Developments
11.23 CSL
11.23.1 CSL Company Details
11.23.2 CSL Business Overview
11.23.3 CSL Prescription Medicine Introduction
11.23.4 CSL Revenue in Prescription Medicine Business (2017-2022)
11.23.5 CSL Recent Developments
11.24 Daiichi Sankyo
11.24.1 Daiichi Sankyo Company Details
11.24.2 Daiichi Sankyo Business Overview
11.24.3 Daiichi Sankyo Prescription Medicine Introduction
11.24.4 Daiichi Sankyo Revenue in Prescription Medicine Business (2017-2022)
11.24.5 Daiichi Sankyo Recent Developments
11.25 Otsuka Holdings
11.25.1 Otsuka Holdings Company Details
11.25.2 Otsuka Holdings Business Overview
11.25.3 Otsuka Holdings Prescription Medicine Introduction
11.25.4 Otsuka Holdings Revenue in Prescription Medicine Business (2017-2022)
11.25.5 Otsuka Holdings Recent Developments
11.26 UCB
11.26.1 UCB Company Details
11.26.2 UCB Business Overview
11.26.3 UCB Prescription Medicine Introduction
11.26.4 UCB Revenue in Prescription Medicine Business (2017-2022)
11.26.5 UCB Recent Developments
11.27 LES LABORATOIRES SERVIER
11.27.1 LES LABORATOIRES SERVIER Company Details
11.27.2 LES LABORATOIRES SERVIER Business Overview
11.27.3 LES LABORATOIRES SERVIER Prescription Medicine Introduction
11.27.4 LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2017-2022)
11.27.5 LES LABORATOIRES SERVIER Recent Developments
11.28 Bausch Health Companies
11.28.1 Bausch Health Companies Company Details
11.28.2 Bausch Health Companies Business Overview
11.28.3 Bausch Health Companies Prescription Medicine Introduction
11.28.4 Bausch Health Companies Revenue in Prescription Medicine Business (2017-2022)
11.28.5 Bausch Health Companies Recent Developments
11.29 Eisai
11.29.1 Eisai Company Details
11.29.2 Eisai Business Overview
11.29.3 Eisai Prescription Medicine Introduction
11.29.4 Eisai Revenue in Prescription Medicine Business (2017-2022)
11.29.5 Eisai Recent Developments
11.30 Abbott Laboratories
11.30.1 Abbott Laboratories Company Details
11.30.2 Abbott Laboratories Business Overview
11.30.3 Abbott Laboratories Prescription Medicine Introduction
11.30.4 Abbott Laboratories Revenue in Prescription Medicine Business (2017-2022)
11.30.5 Abbott Laboratories Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
